Carnegie Investment Counsel’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Buy |
3,210
+10
| +0.3% | +$782 | 0.01% | 489 |
|
|
2025
Q1 | $221K | Sell |
3,200
-900
| -22% | -$62.1K | 0.01% | 470 |
|
|
2024
Q4 | $304K | Sell |
4,100
-120
| -3% | -$8.88K | 0.01% | 398 |
|
|
2024
Q3 | $278K | Sell |
4,220
-1,400
| -25% | -$92.4K | 0.01% | 408 |
|
|
2024
Q2 | $519K | Hold |
5,620
| – | – | 0.02% | 330 |
|
|
2024
Q1 | $537K | Sell |
5,620
-750
| -12% | -$71.7K | 0.02% | 346 |
|
|
2023
Q4 | $486K | Buy |
6,370
+701
| +12% | +$53.5K | 0.02% | 353 |
|
|
2023
Q3 | $393K | Hold |
5,669
| – | – | 0.02% | 377 |
|
|
2023
Q2 | $535K | Sell |
5,669
-250
| -4% | -$23.6K | 0.02% | 342 |
|
|
2023
Q1 | $490K | Sell |
5,919
-14
| -0.2% | -$1.16K | 0.02% | 358 |
|
|
2022
Q4 | $443K | Buy |
5,933
+14
| +0.2% | +$1.05K | 0.02% | 376 |
|
|
2022
Q3 | $489K | Sell |
5,919
-600
| -9% | -$49.6K | 0.02% | 335 |
|
|
2022
Q2 | $620K | Buy |
+6,519
| New | +$620K | 0.03% | 307 |
|
|
2022
Q1 | – | Sell |
-7,209
| Closed | -$934K | – | 495 |
|
|
2021
Q4 | $934K | Sell |
7,209
-1,200
| -14% | -$155K | 0.03% | 277 |
|
|
2021
Q3 | $952K | Buy |
8,409
+500
| +6% | +$56.6K | 0.04% | 251 |
|
|
2021
Q2 | $819K | Sell |
7,909
-75
| -0.9% | -$7.77K | 0.03% | 268 |
|
|
2021
Q1 | $668K | Buy |
7,984
+2,200
| +38% | +$184K | 0.03% | 284 |
|
|
2020
Q4 | $528K | Buy |
5,784
+699
| +14% | +$63.8K | 0.02% | 292 |
|
|
2020
Q3 | $406K | Hold |
5,085
| – | – | 0.02% | 310 |
|
|
2020
Q2 | $351K | Hold |
5,085
| – | – | 0.02% | 325 |
|
|
2020
Q1 | $320K | Sell |
5,085
-459
| -8% | -$28.9K | 0.02% | 318 |
|
|
2019
Q4 | $431K | Sell |
5,544
-228
| -4% | -$17.7K | 0.02% | 320 |
|
|
2019
Q3 | $423K | Sell |
5,772
-360
| -6% | -$26.4K | 0.03% | 318 |
|
|
2019
Q2 | $378K | Buy |
6,132
+504
| +9% | +$31.1K | 0.02% | 341 |
|
|
2019
Q1 | $359K | Buy |
+5,628
| New | +$359K | 0.02% | 343 |
|